Overview

The Effects of Ketamine and Methadone on Postoperative Pain for Laminectomy

Status:
Enrolling by invitation
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to determine the pain-reducing effects of ketamine (Ketalar, an FDA-approved drug for anesthesia) and methadone (Dolophine, a long-acting narcotic) after lumbar laminectomy. The investigators would like to evaluate whether intraoperative use of both drugs may be able to provide better control of pain after lumbar surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Cedars-Sinai Medical Center
Treatments:
Ketamine
Methadone